Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 06 01:11PM ET
0.9916
Dollar change
-0.0184
Percentage change
-1.82
%
Index- P/E- EPS (ttm)-5.08 Insider Own1.75% Shs Outstand6.41M Perf Week-0.39%
Market Cap6.35M Forward P/E- EPS next Y-1.33 Insider Trans0.00% Shs Float6.29M Perf Month4.60%
Income-12.20M PEG- EPS next Q-0.44 Inst Own4.43% Short Float0.81% Perf Quarter1.18%
Sales0.00M P/S- EPS this Y15.65% Inst Trans50.60% Short Ratio0.41 Perf Half Y-37.64%
Book/sh1.00 P/B1.00 EPS next Y56.04% ROA-279.27% Short Interest0.05M Perf Year-54.09%
Cash/sh0.51 P/C1.93 EPS next 5Y- ROE-320.96% 52W Range0.76 - 4.17 Perf YTD-46.69%
Dividend Est.- P/FCF- EPS past 5Y38.36% ROI-285.33% 52W High-76.22% Beta1.31
Dividend TTM- Quick Ratio5.69 Sales past 5Y0.00% Gross Margin- 52W Low29.62% ATR (14)0.06
Dividend Ex-Date- Current Ratio5.69 EPS Y/Y TTM48.41% Oper. Margin0.00% RSI (14)46.05 Volatility3.49% 5.46%
Employees7 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.67 Target Price7.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q57.77% Payout- Rel Volume1.56 Prev Close1.01
Sales Surprise- EPS Surprise-9.26% Sales Q/Q- EarningsAug 19 Avg Volume124.90K Price0.99
SMA20-2.85% SMA50-2.68% SMA200-22.93% Trades Volume114,891 Change-1.82%
Date Action Analyst Rating Change Price Target Change
Oct-30-18Initiated Maxim Group Buy $5
Oct-11-18Initiated Dawson James Buy
Nov-05-24 08:30AM
Oct-23-24 09:00AM
Oct-17-24 09:00AM
08:30AM
Oct-15-24 09:00AM
08:30AM Loading…
Sep-19-24 08:30AM
Sep-04-24 09:00AM
Aug-14-24 08:30AM
Aug-13-24 09:00AM
08:30AM
Aug-07-24 09:00AM
08:30AM
Jul-31-24 08:30AM
Jul-23-24 08:30AM
08:00AM
05:52AM Loading…
Jun-27-24 05:52AM
Jun-20-24 08:30AM
08:00AM
Jun-06-24 07:00AM
Jun-05-24 03:17PM
08:30AM
08:00AM
May-29-24 08:30AM
May-15-24 09:54AM
08:30AM
Apr-22-24 10:00AM
08:30AM
Apr-10-24 11:53AM
08:30AM
Apr-02-24 08:30AM
07:00PM Loading…
Mar-01-24 07:00PM
Feb-28-24 09:30AM
Feb-15-24 09:00AM
Feb-13-24 09:15AM
Jan-18-24 08:30AM
Dec-20-23 09:00AM
Nov-29-23 04:05PM
Nov-14-23 05:02PM
Oct-31-23 08:30AM
Oct-30-23 12:00PM
Oct-25-23 08:00AM
Oct-24-23 04:30PM
Oct-20-23 08:00AM
Oct-19-23 12:00PM
12:00PM
10:30AM
Oct-18-23 08:00AM
Sep-28-23 07:00AM
Sep-05-23 08:30AM
Aug-28-23 08:30AM
Aug-23-23 08:30AM
Aug-21-23 08:30AM
Aug-04-23 08:30AM
Jul-19-23 09:59AM
Jul-11-23 08:30AM
Jun-01-23 09:00AM
May-12-23 08:30AM
May-10-23 08:30AM
Apr-04-23 09:40AM
Mar-30-23 04:05PM
Mar-21-23 09:00AM
Mar-08-23 09:00AM
Mar-07-23 01:51PM
10:46AM
08:05AM
Mar-06-23 04:19PM
Mar-02-23 09:00AM
Feb-28-23 05:27AM
Feb-27-23 09:00AM
Feb-24-23 07:00AM
Feb-21-23 09:00AM
Feb-01-23 09:00AM
Dec-01-22 09:55AM
Nov-14-22 08:30AM
Oct-19-22 04:57PM
Sep-26-22 12:43PM
09:00AM
Sep-06-22 10:02AM
09:00AM
Sep-01-22 09:55AM
Aug-29-22 07:19AM
Aug-26-22 07:42AM
Aug-22-22 04:30PM
Aug-16-22 09:15AM
Jul-20-22 07:00AM
06:45AM
Jul-18-22 09:25AM
Jun-28-22 11:49AM
Jun-27-22 09:16AM
Jun-14-22 10:48AM
09:55AM
May-19-22 09:25AM
May-16-22 09:25AM
May-05-22 04:05PM
May-04-22 09:15AM
Apr-06-22 07:47AM
Mar-22-22 09:15AM
Feb-24-22 09:15AM
Feb-16-22 09:26AM
Feb-11-22 09:00AM
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.